BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Takeda Global Research & Development Center, Inc. 

One Takeda Parkway

Deerfield  Illinois  60015  U.S.A.
Phone: 224-554-6500 Fax: n/a


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Takeda Global Research & Development Center, Inc. Progressing Well in Asia With New Drug Applications (NDA) 10/4/2012 10:15:58 AM
Takeda Global Research & Development Center, Inc. Launches Phase III Clinical Trial in Asia for "TAK-875", a Potential Diabetic Treatment 9/26/2012 9:34:40 AM
Furiex Pharmaceuticals, Inc. (FURX) Confirms Takeda Global Research & Development Center, Inc.'s Announcement on the Acceptance of the EMA Submissions for Two Fixed-Dose Alogliptin Combination Therapies for the Treatment of Type 2 Diabetes 6/19/2012 10:06:04 AM
Affymax, Inc. (AFFY) and Takeda Global Research & Development Center, Inc. Report Additional Analyses of Peginesatide Phase 3 Studies in Dialysis Patients at the American Society of Nephrology’s Kidney Week 2011 11/11/2011 8:04:11 AM
Takeda Global Research & Development Center, Inc. Announces PDUFA Action Date for Investigational Type 2 Diabetes Therapies Alogliptin and the Fixed-Dose Combination Alogliptin/Pioglitazone 11/1/2011 6:51:39 AM
Affymax, Inc. (AFFY) and Takeda Global Research & Development Center, Inc. Announce FDA Acceptance of New Drug Application for Peginesatide 7/27/2011 7:33:26 AM
Takeda Global Research & Development Center, Inc. New Head-to-Head Phase 3 Study Evaluated Systolic Blood Pressure Reduction of Investigational Compound Azilsartan Medoxomil Compared to Valsartan 6/21/2010 9:55:21 AM
Affymax, Inc. (AFFY) and Takeda Global Research & Development Center, Inc. Announce Phase 3 Trials Meet Primary Endpoints for Investigational Drug, Hematide(TM)/peginesatide, to Treat Anemia in Chronic Renal Failure With Some Differences Noted in Secondary Analyses 6/21/2010 9:04:47 AM
Affymax, Inc. (AFFY) and Takeda Global Research & Development Center, Inc. Report Phase 2 Analyses of Hematide(TM)/peginesatide in Hemodialysis Patients 4/15/2010 8:33:33 AM
Affymax, Inc. (AFFY) and Takeda Global Research & Development Center, Inc. to Present HematideTM/peginesatide Phase 2 Data at the National Kidney Foundation 2010 Spring Meeting 3/30/2010 8:38:28 AM
12